Fort Worth, Texas, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AppYea, Inc. (OTCPK:APYP, or the "Company"), which
previously announced its move into Hemp based CBD infused products, announced today that the company has received and fulfilled its
first purchase order from Hempori, Inc. (“Hempori”). The purchase order is for various skus of hemp derived CBD infused
products.
“We have now begun to source and supply products to Hempori for sale in their retail outlets. The company is excited and
optimistic about the projected success to come,” says Doug McKinnon, the Company’s CEO.
“We continue to look forward to growing our supply relationship with AppYea,” states Grant Magers, CEO
Hempori.
About Hempori
The Hempori brand is active in the Hemp industry and has over 75 products that are sold in its own stores and
other retail locations throughout the state of Texas, online via Hempori.com, and other online sales channels under
development. Hempori is also in the process of developing additional unique proprietary products in the Hemp industry.
In addition, the management team of Hempori provides private and public business development consulting services in the Hemp and
CBD industries. Grant Magers is the CEO and Co-Founder of Hempori, Inc. and has multiple degrees including an MBA from
Southern Methodist University as well as an MS and BA from Texas Tech University. As CEO of Hempori, Mr. Magers’ primary
responsibility to his partners and shareholders is to grow profitability while maintaining operational efficiency, budgetary
integrity, and legislative compliance.
About AppYea, Inc.
AppYea Inc., founded in 2012, is engaged in mobile applications for iOS, Google Play, and Amazon platforms, marketing
certain products and services to healthcare providers and now Hemp based CBD infused products. Through its wholly owned
subsidiary, The Diagnostic Centers, Inc., AppYea markets comprehensive diagnostic testing services to physician offices, clinics,
hospitals, long term care facilities, healthcare groups, and other healthcare providers. The Company is headquartered in Ft Worth,
Texas and trades under the symbol APYP. For more information about AppYea, visit website: http://appyea.com/about/
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of
1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or
forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and
unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially
from the forward-looking statements contained in this press release. Additional information respecting the factors that could
materially affect the Company and its operations are contained in its annual report on Form 10K and Form 10-Q as filed with the
Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking
statement.
Contact information: Investor Relations Phone: (817) 887-8142